These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21270061)

  • 21. Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.
    Fujito T; Sasaki Y; Iwao K; Miyoshi Y; Yamada T; Ohigashi H; Ishikawa O; Imaoka S
    Hepatogastroenterology; 2004; 51(58):921-4. PubMed ID: 15239213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced expression and clinical significance of chemokine receptor CXCR2 in hepatocellular carcinoma.
    Liu Z; Yang L; Xu J; Zhang X; Wang B
    J Surg Res; 2011 Apr; 166(2):241-6. PubMed ID: 20018298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma.
    Amaoka N; Saio M; Nonaka K; Imai H; Tomita H; Sakashita F; Takahashi T; Sugiyama Y; Takami T; Adachi Y
    Oncol Rep; 2006 Jul; 16(1):3-10. PubMed ID: 16786116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria.
    Aucejo F; Kim R; Zein N; Quintini C; Uso TD; Lopez R; Eghtesad B; Fung J; Miller C; Yerian L
    Liver Transpl; 2009 Feb; 15(2):169-76. PubMed ID: 19177438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma.
    Liang XT; Pan K; Chen MS; Li JJ; Wang H; Zhao JJ; Sun JC; Chen YB; Ma HQ; Wang QJ; Xia JC
    J Gastroenterol Hepatol; 2011 Mar; 26(3):544-9. PubMed ID: 21332550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.
    Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D
    Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up.
    Rydén L; Jirström K; Haglund M; Stål O; Fernö M
    Breast Cancer Res Treat; 2010 Apr; 120(2):491-8. PubMed ID: 20135347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma.
    Ma S; Guan XY; Lee TK; Chan KW
    Hum Pathol; 2007 Aug; 38(8):1201-6. PubMed ID: 17442377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC
    Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
    Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.
    Nanashima A; Yano H; Yamaguchi H; Tanaka K; Shibasaki S; Sumida Y; Sawai T; Shindou H; Nakagoe T
    J Gastroenterol; 2004; 39(2):148-54. PubMed ID: 15069621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effects of the expression of VEGF and KDR on the angiogenesis, growth and metastasis of hepatocellular carcinoma].
    Zhao A; Dou K; Li K; Fu Y
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):453-6. PubMed ID: 11832083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B; Pappot H; Holmstav J; Skov BG
    Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
    Sieghart W; Losert D; Strommer S; Cejka D; Schmid K; Rasoul-Rockenschaub S; Bodingbauer M; Crevenna R; Monia BP; Peck-Radosavljevic M; Wacheck V
    J Hepatol; 2006 Jan; 44(1):151-7. PubMed ID: 16289418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer.
    Xia G; Kumar SR; Hawes D; Cai J; Hassanieh L; Groshen S; Zhu S; Masood R; Quinn DI; Broek D; Stein JP; Gill PS
    J Urol; 2006 Apr; 175(4):1245-52. PubMed ID: 16515971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.